Friday, October 9, 2020

U.S. signs agreement with AstraZeneca to develop COVID-19 antibody treatment

The agency will provide nearly $486 million to AstraZeneca for two Phase 3 clinical trials

from The Hindu - International https://ift.tt/3nAoa4k
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)